» Articles » PMID: 37725066

Strategies for Applying Probiotics in the Antibiotic Management of Infection

Overview
Journal Food Funct
Date 2023 Sep 19
PMID 37725066
Authors
Affiliations
Soon will be listed here.
Abstract

The vital role of probiotics in the food field has been widely recognized, and at the same time, probiotics are gradually exhibiting surprising effects in the field of nutraceuticals, especially in regulating gut inflammation and the nutritional environment. As a dietary supplement in clinical nutrition, the coadministration of probiotics with antibiotics model has been applied to prevent intestinal infections caused by . However, the mechanism behind this "bacteria-drug combination" model remains unclear. In particular, the selection of specific probiotic strains, the order of probiotics or antibiotics, and the time interval of coadministration are key issues that need to be further explored and clarified. Here, we focus on the issues mentioned above and give reasonable opinions, mainly including: (1) probiotics are safer and more effective when they intervene after antibiotics have been used; (2) the choice of the time interval between coadministration should be based on the metabolism of antibiotics in the host, differences in probiotic strains, the baseline ecological environment of the host's intestine, and the host immune level; in addition, the selection of the coadministration regime should also take into account factors such as the antibiotic sensitivity of probiotics and dosage of probiotics; and (3) by encapsulating probiotics, combining probiotics with prebiotics, and developing next-generation probiotics (NGPs) and postbiotic formulations, we can provide a more reasonable reference for this type of "bacteria-drug combination" model, and also provide targeted guidance for the application of probiotic dietary supplements in the antibiotic management of infection.

Citing Articles

Targeting Spore-Forming Bacteria: A Review on the Antimicrobial Potential of Selenium Nanoparticles.

Ahmed F, Zhang D, Tang X, Malakar P Foods. 2025; 13(24.

PMID: 39766969 PMC: 11728422. DOI: 10.3390/foods13244026.


A Critical Review of Postbiotics as Promising Novel Therapeutic Agents for Clostridial Infections.

Ozma M, Fadaee M, Mahmoodzadeh Hosseini H, Ataee M, Mirhosseini S Probiotics Antimicrob Proteins. 2024; .

PMID: 39546182 DOI: 10.1007/s12602-024-10406-0.


Unraveling the antimicrobial potential of strains TE0907 and TE1809 sourced from : advancing the frontier of probiotic-based therapeutics.

Huang F, Zhao Y, Hou Y, Yang Y, Yue B, Zhang X Front Microbiol. 2024; 15:1347830.

PMID: 38419633 PMC: 10899456. DOI: 10.3389/fmicb.2024.1347830.


Innovative Biomedical and Technological Strategies for the Control of Bacterial Growth and Infections.

Matias L, Damasceno K, Pereira A, Passos T, de Araujo Morais A Biomedicines. 2024; 12(1).

PMID: 38255281 PMC: 10813423. DOI: 10.3390/biomedicines12010176.